Neptune Technologies Patent Granted for Novel Phospholipids in Multiple Diseases and Pharmaceutical Applications.

PR Newswire Europe, March, 2008

LAVAL, Canada, March 27 /PRNewswire/ --

- Composition of Matter Patent Granted and Enforceable in 24 European Countries

- Competitors Precluded From Immediate Commercialisation of Competitive Products

Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ: NEPT - TSX.V.NTB) announces that the European Patent Office (EPO) granted on May 31st 2007 Neptune's composition of matter patent entitled, "Natural Marine Source Phospholipids comprising flavonoA[macron]ds, polyunsaturated fatty acids and their applications" (EP01417211B1) and that this patent has now been issued and validated in twenty-four European countries.

This patent is directed to the use of Neptune marine phospholipid and flavonoA[macron]d compositions as a...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement